Position in FTRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$292,285
+$216,785 QoQ
Shares Held
16,798
+68.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#163
of 331 holders
Holding Since
Mar 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Massar Capital Management, LP holds $10,038,555 across 6 Biotechnology names. FTRE ranks #4 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
18,695 | $4,504,934 | |
| 2 | QURE |
uniQure N.V.
|
61,314 | $2,824,122 | |
| 3 | CYTK |
Cytokinetics Inc
|
27,698 | $2,359,592 | |
| 4 | FTRE |
Fortrea Holdings Inc.
This page
|
16,798 | $292,285 | |
| 5 | AVXL |
Anavex Life Sciences Corp.
|
12,729 | $32,968 | |
| 6 | IVVD |
Invivyd, Inc.
|
28,273 | $24,654 |
All Filings in FTRE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $292,285 | 16,798 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $75,500 | 10,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||